Company Overview of Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. researches, develops, and manufactures pharmaceutical products for the treatment of a variety of cancer, gastrointestinal and metabolic conditions. The company was formerly known as Sapphire Therapeutics Inc. and changed its name to Helsinn Therapeutics (U.S.), Inc. in January, 2009. The company was founded in 2000 and is based in Iselin, New Jersey. As of January 28, 2009, Helsinn Therapeutics (U.S.), Inc. operates as a subsidiary of Helsinn Healthcare S.A.
170 Wood Avenue South
Iselin, NJ 08830
Founded in 2000
Key Executives for Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Key Developments
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Helsinn Therapeutics (U.S.), Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.